MedAssurant Earns 2011 NCQA Full Accreditation for Disease Management Programs
Asthma, Chronic Obstructive Pulmonary Disease (COPD), Coronary Artery Disease, Chronic Heart Failure (CHF) and Diabetes Programs Recognized for Ongoing Commitment to Industry Excellence
BOWIE, Md. – March 31, 2011 – MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that it has received Full Patient and Practitioner Oriented Disease Management Accreditation from the National Committee for Quality Assurance (NCQA) for its CCS Advantage™ programs for asthma, COPD, coronary artery disease, CHF and diabetes. This accreditation is in addition to MedAssurant’s recent NCQA Software Certification for its Quality Spectrum Insights (QSI™) application, a Healthcare Effectiveness Data and Information Set (HEDIS®) measurement and reporting solution.
“Today, only 56 percent of chronically ill patients receive the care they need,” said Hammad Shah, R. Ph., M.B.A., MedAssurant’s chief strategy officer. “Developing solutions for managing chronic disease that meet the specific care needs of each patient are crucial, and MedAssurant’s CCS Advantage solution delivers unparalleled patient-level specificity in this arena. This year’s NCQA Accreditation underscores MedAssurant’s commitment to industry excellence and to providing high-quality innovative solutions that combine advanced data analytics and deep clinical insight to enable health plans and employers to best manage the care of their chronically ill patients.”
NCQA is an independent, not-for-profit organization dedicated to measuring the quality of America’s health care. NCQA Disease Management Accreditation is a voluntary process, and its standards are developed with input from experts and researchers in the field, the Disease Management Advisory Council, purchasers and operators of disease management programs, state and federal regulators and other experts. Accreditation indicates that a disease management program is dedicated to giving patients and/or practitioners the necessary infrastructure and support to facilitate good clinical outcomes and high-quality care.
About CCS Advantage
MedAssurant’s CCS Advantage delivers a data-driven, patient-specific solution that enables national and regional health plans and employers to deliver an unparalleled, comprehensive disease management capability with superior benefits to quality of care, clinical outcomes, results transparency, and financial performance. CCS Advantage delivers a unique combination of electronic, print, call-center and in-market-based resources to achieve optimal communication, intervention and coordination of care for each patient – at patient-specific levels of stratification, prioritization and need.
About MedAssurant, Inc.
MedAssurant, Inc., is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empower MedAssurant’s advanced generation of healthcare assessment and improvement solutions. Driven by a mission to improve today’s healthcare landscape, the employees of MedAssurant proudly apply care, ingenuity and dedication to delivering a new approach to healthcare touching more than 100 million Americans – one driven by data and insight – one resulting in meaningful action.
Contacts
Russo Partners LLC on behalf of
MedAssurant, Inc.
Tony Russo or Lena Evans
Phone: 212-845-4251
Phone: 212-845-4262
tony.russo@russopartnerslic.com
MedAssurant, Inc.
Alex Burgess
4321 Collington Road
Bowie, Maryland 20716
aburgess@medassurant.com